Ozempic Savings Card: How to Pay $25/Month and Eligibility Rules

How the Ozempic Savings Card Works

The Ozempic savings card is a manufacturer copay assistance program offered by Novo Nordisk through their NovoCare patient support program.

How it reduces your cost: The card acts as a secondary payer at the pharmacy. After your insurance pays its portion, the savings card covers the remainder — up to a monthly maximum.

Monthly copay limits with the savings card:

• 1-month supply: You pay a minimum of $25, maximum of $150
• 3-month supply: You pay a minimum of $75, maximum of $450

For patients with insurance plans that cover Ozempic with a low copay structure, the out-of-pocket is typically $25–50/month. For patients with higher deductibles, the savings card caps exposure at $150/month regardless of deductible progress.

Eligibility Requirements

You qualify if:

• You have commercial insurance (employer-sponsored, individual market, ACA marketplace)
• Ozempic is prescribed for an FDA-approved indication (type 2 diabetes)
• Your insurance plan covers Ozempic (or has a path to coverage)

You do not qualify if:

• You have Medicare Part D
• You have Medicaid or CHIP
• You have TRICARE, VA benefits, or other federal/state government insurance
• You are uninsured (a different program — NovoCare — applies instead)

No income limit applies to the commercial savings card program.

Getting the Savings Card

Option 1 — Online activation: Visit ozempicpro.com or novocare.com to enroll online. You'll need your insurance information and Ozempic prescription details.

Option 2 — Through your prescriber: Many prescribers' offices handle savings card enrollment during the appointment when Ozempic is prescribed. Ask if they have NovoCare enrollment support.

Option 3 — At the pharmacy: Some pharmacies have savings card information available. Present it with your prescription at the pharmacy counter.

The card is valid for multiple fills and resets annually. Re-enrollment may be required each year.

What If Your Insurance Doesn't Cover Ozempic?

Ozempic is generally well-covered for type 2 diabetes — it's on most commercial formularies as either a preferred brand or non-preferred brand. However:

If Ozempic is not covered:

• Request a prior authorization: Your prescriber can submit PA documentation showing medical necessity
• Try metformin first: Many plans require documented failure of metformin (or other first-line diabetes drugs) before approving GLP-1 medications
• Formulary exception: If Ozempic has superior clinical justification for a specific patient, formulary exceptions are sometimes granted

If coverage is denied:

• Appeal the denial — denial reversal rates for GLP-1 medications with proper documentation are meaningful
• Check if a different GLP-1 (Mounjaro, Trulicity) has better formulary placement and switch discussions with your prescriber

NovoCare Patient Assistance Program (Uninsured/Underinsured)

For patients who don't have insurance or whose insurance doesn't cover Ozempic, Novo Nordisk's NovoCare Patient Assistance Program may provide Ozempic at no cost:

Eligibility (approximate — subject to program changes):

• Annual income below 400% of the federal poverty level (~$58,000 for individuals in 2026)
• No insurance covering Ozempic
• US residency

Applications are processed through novocare.com or by calling NovoCare directly. Processing takes several weeks; bridge supplies are sometimes available.

Ozempic vs. Wegovy Savings: Key Differences

Both contain semaglutide. Key differences in savings programs:

Ozempic's slightly higher minimum ($25 vs. $0) reflects its different insurance coverage dynamics. Wegovy's obesity indication faces more formulary restriction, which is why the program structure differs.

Ozempic for Weight Loss: Off-Label Coverage

Some patients without type 2 diabetes receive Ozempic off-label for weight loss. In this case:

• Insurance is unlikely to cover it as a diabetes medication without a diabetes diagnosis
• The savings card technically applies to FDA-approved uses (type 2 diabetes)
• Using Ozempic off-label for weight loss with a savings card may require clarification with the prescriber and pharmacy

Patients using semaglutide specifically for weight loss without diabetes are generally better served by Wegovy (the FDA-approved obesity indication) if insurance coverage for obesity drugs exists on their plan.

Bottom Line

The Ozempic savings card reduces monthly out-of-pocket to $25–150 for commercially insured patients with Ozempic on their formulary. Medicare and Medicaid patients are excluded — separate programs apply. The NovoCare Patient Assistance Program covers uninsured patients below income thresholds at no cost. For patients using semaglutide specifically for obesity rather than diabetes, the Wegovy savings card and its associated insurance landscape is the more relevant pathway.

Sources

• Novo Nordisk, NovoCare Patient Support Program
• Novo Nordisk, Ozempic OzempicPro Savings Program
• Wilding JPH et al., "Once-Weekly Semaglutide in Adults with Overweight or Obesity," NEJM, 2021
• KFF, "Tracking Prescription Drug Coverage in Medicare Part D," 2024